251 related articles for article (PubMed ID: 22370659)
1. Iris melanoma: features and prognosis in 317 children and adults.
Shields CL; Kaliki S; Shah SU; Luo W; Furuta M; Shields JA
J AAPOS; 2012 Feb; 16(1):10-6. PubMed ID: 22370659
[TBL] [Abstract][Full Text] [Related]
2. Iris melanoma: risk factors for metastasis in 169 consecutive patients.
Shields CL; Shields JA; Materin M; Gershenbaum E; Singh AD; Smith A
Ophthalmology; 2001 Jan; 108(1):172-8. PubMed ID: 11150284
[TBL] [Abstract][Full Text] [Related]
3. Iris nevus growth into melanoma: analysis of 1611 consecutive eyes: the ABCDEF guide.
Shields CL; Kaliki S; Hutchinson A; Nickerson S; Patel J; Kancherla S; Peshtani A; Nakhoda S; Kocher K; Kolbus E; Jacobs E; Garoon R; Walker B; Rogers B; Shields JA
Ophthalmology; 2013 Apr; 120(4):766-72. PubMed ID: 23290981
[TBL] [Abstract][Full Text] [Related]
4. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
[TBL] [Abstract][Full Text] [Related]
5. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases.
Shields CL; Kaliki S; Furuta M; Mashayekhi A; Shields JA
Retina; 2012 Jul; 32(7):1363-72. PubMed ID: 22466491
[TBL] [Abstract][Full Text] [Related]
6. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.
Shields CL; Kaliki S; Livesey M; Walker B; Garoon R; Bucci M; Feinstein E; Pesch A; Gonzalez C; Lally SE; Mashayekhi A; Shields JA
JAMA Ophthalmol; 2013 Aug; 131(8):993-1003. PubMed ID: 23681424
[TBL] [Abstract][Full Text] [Related]
7. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
Shields CL; Di Nicola M; Bekerman VP; Kaliki S; Alarcon C; Fulco E; Shields JA
Ophthalmology; 2018 Jun; 125(6):913-923. PubMed ID: 29342436
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with elevated intraocular pressure in eyes with iris melanoma.
Shields CL; Materin MA; Shields JA; Gershenbaum E; Singh AD; Smith A
Br J Ophthalmol; 2001 Jun; 85(6):666-9. PubMed ID: 11371484
[TBL] [Abstract][Full Text] [Related]
9. Influence of age on prognosis of young patients with uveal melanoma: a matched retrospective cohort study.
Kaliki S; Shields CL; Mashayekhi A; Ganesh A; Furuta M; Shields JA
Eur J Ophthalmol; 2013; 23(2):208-16. PubMed ID: 23065853
[TBL] [Abstract][Full Text] [Related]
10. Uveal melanoma in teenagers and children. A report of 40 cases.
Shields CL; Shields JA; Milite J; De Potter P; Sabbagh R; Menduke H
Ophthalmology; 1991 Nov; 98(11):1662-6. PubMed ID: 1800926
[TBL] [Abstract][Full Text] [Related]
11. No differences in the long-term prognosis of iris and choroidal melanomas when adjusting for tumor thickness and diameter.
Sabazade S; Herrspiegel C; Gill V; Stålhammar G
BMC Cancer; 2021 Nov; 21(1):1270. PubMed ID: 34819035
[TBL] [Abstract][Full Text] [Related]
12. Iris melanoma: Review of clinical features, risks, management, and outcomes.
Cherkas E; Kalafatis NE; Marous MR; Shields CL
Clin Dermatol; 2024; 42(1):62-70. PubMed ID: 37865279
[TBL] [Abstract][Full Text] [Related]
13. Diffuse iris melanoma: a report of 25 cases.
Demirci H; Shields CL; Shields JA; Eagle RC; Honavar SG
Ophthalmology; 2002 Aug; 109(8):1553-60. PubMed ID: 12153810
[TBL] [Abstract][Full Text] [Related]
14. American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients.
Shields CL; Kaliki S; Furuta M; Fulco E; Alarcon C; Shields JA
Ophthalmology; 2013 Oct; 120(10):2066-71. PubMed ID: 23664467
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study.
Khan S; Finger PT; Yu GP; Razzaq L; Jager MJ; de Keizer RJ; Sandkull P; Seregard S; Gologorsky D; Schefler AC; Murray TG; Kivelä T; Giuliari GP; McGowan H; Simpson ER; Corriveau C; Coupland SE; Damato BE
Arch Ophthalmol; 2012 Jan; 130(1):57-64. PubMed ID: 21911649
[TBL] [Abstract][Full Text] [Related]
16. Melanoma of the eye: revealing hidden secrets, one at a time.
Shields CL; Kels JG; Shields JA
Clin Dermatol; 2015; 33(2):183-96. PubMed ID: 25704938
[TBL] [Abstract][Full Text] [Related]
17. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
Coupland SE; Campbell I; Damato B
Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
[TBL] [Abstract][Full Text] [Related]
18. Plaque radiotherapy for residual or recurrent iris melanoma after surgical resection in 32 cases.
Shah SU; Shields CL; Bianciotto C; Emrich J; Komarnicky L; Shields JA
Ophthalmology; 2012 Apr; 119(4):838-842.e2. PubMed ID: 22133794
[TBL] [Abstract][Full Text] [Related]
19. Management and Outcome of Uveal Melanoma in a Single Tertiary Cancer Center in Jordan.
Zewar A; Nawaiseh I; Jaradat I; Khzouz J; Alrawashdeh K; Abdeen G; Mehyar M; Khurma S; Yousef YA
Turk Patoloji Derg; 2016; 32(3):186-92. PubMed ID: 27562393
[TBL] [Abstract][Full Text] [Related]
20. Diffuse Anterior Retinoblastoma with Globe Salvage and Visual Preservation in 3 Consecutive Cases.
Shields CL; Lally SE; Manjandavida FP; Leahey AM; Shields JA
Ophthalmology; 2016 Feb; 123(2):378-384. PubMed ID: 26522706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]